Search
Q&A
Groups
Sign In
Pfizer’s Abrocitinib Meets Endpoints in Phase 3 JADE TEEN Study for Atopic Dermatitis
9218
0 comment
trialsitenews
Staff at TrialSite | Quality Journalism
Jun. 11, 2020, 8:30 p.m.
Company
About Us
Terms of Service
Privacy Policy
Contact Us
Publish on TrialSite
Writing Best Practices
Why TrialSite?
Follow Us
YouTube
Twitter
Facebook
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2024 - Trial Site News